Dr. Christoph Schröder joined TVM Capital in 2005 as a Life Science Venture Partner. He is a seasoned healthcare and pharma executive with experience at BASF Pharma and numerous private investments in European and U.S. biotech companies. He has successfully managed more than 80 M&A and licensing transactions with an aggregated transaction volume of more than € 5bn on behalf of clients in the life sciences, healthcare and biotech industries.
At BASF Pharma he was a member of the company’s London-based Executive Board and was President of two corporate functions: Global Production/Supply Chain and Corporate Marketing. Prior to this, Dr. Schröder was Head of Strategy/M&A and Managing Director for BASF Pharma’s operations in the UK and Ireland.
Following BASF Pharma’s acquisition by Abbott Laboratories in 2001, Dr. Schröder became a partner with JSB Partners, L.P., a specialized transatlantic investment banking and advisory firm in the life sciences industry, with offices in Berlin, Boston and Munich. In this capacity, he successfully executed several private placements, M&A and licensing transactions on behalf of biotech clients.
As a board member for several private companies and institutions, Dr. Schröder plays a key role advising companies regarding investments and transactions. On behalf of TVM Capital, he currently holds a board seat at Riemser AG (Greifswald/Leipzig, Germany).
Dr. Schröder earned his Ph.D. in Finance from the Technische Universität in Berlin and graduated in Business Administration from Ludwig Maximilians-Universität in Munich.
